Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

592 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
Axelsson Raja A, Farhad H, Valente AM, Couce JP, Jefferies JL, Bundgaard H, Zahka K, Lever H, Murphy AM, Ashley E, Day SM, Sherrid MV, Shi L, Bluemke DA, Canter CE, Colan SD, Ho CY. Axelsson Raja A, et al. Among authors: bundgaard h. Circulation. 2018 Aug 21;138(8):782-792. doi: 10.1161/CIRCULATIONAHA.117.032966. Circulation. 2018. PMID: 29622585 Free PMC article.
Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy.
Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M, Maron BJ, Orav EJ, Køber L. Ho CY, et al. Among authors: bundgaard h. Circ Cardiovasc Genet. 2009 Aug;2(4):314-21. doi: 10.1161/CIRCGENETICS.109.862128. Epub 2009 Jun 19. Circ Cardiovasc Genet. 2009. PMID: 20031602 Free PMC article.
Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study.
Jensen MK, Almaas VM, Jacobsson L, Hansen PR, Havndrup O, Aakhus S, Svane B, Hansen TF, Køber L, Endresen K, Eriksson MJ, Jørgensen E, Amlie JP, Gadler F, Bundgaard H. Jensen MK, et al. Among authors: bundgaard h. Circ Cardiovasc Interv. 2011 Jun;4(3):256-65. doi: 10.1161/CIRCINTERVENTIONS.110.959718. Epub 2011 May 3. Circ Cardiovasc Interv. 2011. PMID: 21540441
Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.
Lakdawala NK, Thune JJ, Maron BJ, Cirino AL, Havndrup O, Bundgaard H, Christiansen M, Carlsen CM, Dorval JF, Kwong RY, Colan SD, Køber LV, Ho CY. Lakdawala NK, et al. Among authors: bundgaard h. Am J Cardiol. 2011 Dec 1;108(11):1606-13. doi: 10.1016/j.amjcard.2011.07.019. Epub 2011 Sep 21. Am J Cardiol. 2011. PMID: 21943931 Free PMC article.
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial.
Axelsson A, Iversen K, Vejlstrup N, Ho C, Norsk J, Langhoff L, Ahtarovski K, Corell P, Havndrup O, Jensen M, Bundgaard H. Axelsson A, et al. Among authors: bundgaard h. Lancet Diabetes Endocrinol. 2015 Feb;3(2):123-31. doi: 10.1016/S2213-8587(14)70241-4. Epub 2014 Dec 19. Lancet Diabetes Endocrinol. 2015. PMID: 25533774 Clinical Trial.
Left ventricular volume predicts exercise capacity in hypertrophic cardiomyopathy.
Axelsson A, Iversen K, Vejlstrup N, Langhoff L, Thomsen A, Ho CY, Havndrup O, Kofoed KF, Jensen M, Bundgaard H. Axelsson A, et al. Among authors: bundgaard h. Int J Cardiol. 2016 Jan 15;203:676-8. doi: 10.1016/j.ijcard.2015.11.029. Epub 2015 Nov 6. Int J Cardiol. 2016. PMID: 26583841 No abstract available.
592 results